セベラマー市場2020：地域の見通し（アメリカ、ヨーロッパ、アジア太平洋、中東、アフリカ）別のサイズ、業界分析レポート、成長の可能性、価格動向、競争力のある市場シェア、市場統計と予測2020-2025 (アップデート版あり)

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Sevelamer Market Size Growth Rate by Type (2020-2025)
1.3.2 Tablet
1.3.3 Oral suspension
1.4 Market Segment by Application
1.4.1 Global Sevelamer Market Share by Application (2020-2025)
1.4.2 Adult
1.4.3 Pediatric
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Sevelamer Market Size
2.1.1 Global Sevelamer Revenue 2015-2025
2.1.2 Global Sevelamer Sales 2015-2025
2.2 Sevelamer Growth Rate by Regions
2.2.1 Global Sevelamer Sales by Regions 2015-2019
2.2.2 Global Sevelamer Revenue by Regions 2015-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Sevelamer Sales by Manufacturers
3.1.1 Sevelamer Sales by Manufacturers 2015-2019
3.1.2 Sevelamer Sales Market Share by Manufacturers 2015-2019
3.2 Revenue by Manufacturers
3.2.1 Sevelamer Revenue by Manufacturers (2015-2019)
3.2.2 Sevelamer Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Sevelamer Market Concentration Ratio (CR5 and HHI)
3.3 Sevelamer Price by Manufacturers
3.4 Key Manufacturers Sevelamer Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Sevelamer Market
3.6 Key Manufacturers Sevelamer Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Tablet Sales and Revenue (2015-2019)
4.1.2 Oral suspension Sales and Revenue (2015-2019)
4.2 Global Sevelamer Sales Market Share by Type
4.3 Global Sevelamer Revenue Market Share by Type
4.4 Sevelamer Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Sevelamer Sales by Application

6 United States
6.1 United States Sevelamer Breakdown Data by Company
6.2 United States Sevelamer Breakdown Data by Type
6.3 United States Sevelamer Breakdown Data by Application

7 European Union
7.1 European Union Sevelamer Breakdown Data by Company
7.2 European Union Sevelamer Breakdown Data by Type
7.3 European Union Sevelamer Breakdown Data by Application

8 China
8.1 China Sevelamer Breakdown Data by Company
8.2 China Sevelamer Breakdown Data by Type
8.3 China Sevelamer Breakdown Data by Application

9 Rest of World
9.1 Rest of World Sevelamer Breakdown Data by Company
9.2 Rest of World Sevelamer Breakdown Data by Type
9.3 Rest of World Sevelamer Breakdown Data by Application
9.4 Rest of World Sevelamer Breakdown Data by Countries
9.4.1 Rest of World Sevelamer Sales by Countries
9.4.2 Rest of World Sevelamer Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia

10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Sevelamer
10.1.4 Sevelamer Product Introduction
10.1.5 Sanofi Recent Development
10.2 Impax Laboratories
10.2.1 Impax Laboratories Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Sevelamer
10.2.4 Sevelamer Product Introduction
10.2.5 Impax Laboratories Recent Development
10.3 InvaGen Pharmaceuticals
10.3.1 InvaGen Pharmaceuticals Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Sevelamer
10.3.4 Sevelamer Product Introduction
10.3.5 InvaGen Pharmaceuticals Recent Development
10.4 Dr. Reddy\'s Laboratories
10.4.1 Dr. Reddy\'s Laboratories Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Sevelamer
10.4.4 Sevelamer Product Introduction
10.4.5 Dr. Reddy\'s Laboratories Recent Development
10.5 Aurobindo Pharma
10.5.1 Aurobindo Pharma Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Sevelamer
10.5.4 Sevelamer Product Introduction
10.5.5 Aurobindo Pharma Recent Development
10.6 Amneal Pharmaceuticals
10.6.1 Amneal Pharmaceuticals Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Sevelamer
10.6.4 Sevelamer Product Introduction
10.6.5 Amneal Pharmaceuticals Recent Development

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Sevelamer Sales Channels
11.2.2 Sevelamer Distributors
11.3 Sevelamer Customers

12 Market Forecast
12.1 Global Sevelamer Sales and Revenue Forecast 2020-2025
12.2 Global Sevelamer Sales Forecast by Type
12.3 Global Sevelamer Sales Forecast by Application
12.4 Sevelamer Forecast by Regions
12.4.1 Global Sevelamer Sales Forecast by Regions 2020-2025
12.4.2 Global Sevelamer Revenue Forecast by Regions 2020-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer